CSF biomarker variability in the Alzheimer’s Association quality control program

A call for standardization due to CSF biomarker variability to ensure quality control

Read more

The CSF biomarkers amyloid beta 1–42, total tau, and phosphorylated tau are used increasingly for Alzheimer’s disease research and patient management. However, there are large variations in biomarker measurements among and within laboratories.

Want to learn more about Worldwide Clinical Trials?